CHRM5 and myalgic encephalomeyelitis/chronic fatigue syndrome: Except for CHRM5-Ab, differences in AAB levels between patient groups were found only after adjustment for age, gender, and disease duration (time after infection), indicating that PCS patients with and without ME/CFS only barely differ in their AAB levels.